Souders Financial Advisors Has $1.09 Million Holdings in Elevance Health, Inc. (NYSE:ELV)

Souders Financial Advisors trimmed its stake in Elevance Health, Inc. (NYSE:ELV) by 10.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 2,944 shares of the company’s stock after selling 349 shares during the period. Souders Financial Advisors’ holdings in Elevance Health were worth $1,086,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Raelipskie Partnership acquired a new stake in Elevance Health during the third quarter worth about $26,000. Dunhill Financial LLC increased its position in shares of Elevance Health by 57.8% during the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock valued at $37,000 after purchasing an additional 26 shares during the period. Peterson Financial Group Inc. acquired a new position in shares of Elevance Health in the third quarter valued at $44,000. Crews Bank & Trust acquired a new position in shares of Elevance Health in the 4th quarter valued at $34,000. Finally, Prospera Private Wealth LLC bought a new position in shares of Elevance Health during the 3rd quarter worth about $52,000. Institutional investors own 89.24% of the company’s stock.

Elevance Health Stock Up 0.6 %

NYSE ELV opened at $397.68 on Wednesday. The stock has a market capitalization of $90.41 billion, a P/E ratio of 15.53, a price-to-earnings-growth ratio of 1.18 and a beta of 0.83. Elevance Health, Inc. has a 52 week low of $362.21 and a 52 week high of $567.26. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.50 and a current ratio of 1.45. The stock has a fifty day moving average of $388.77 and a 200-day moving average of $436.31.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, topping analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%. On average, equities research analysts forecast that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th will be issued a dividend of $1.71 per share. This represents a $6.84 dividend on an annualized basis and a yield of 1.72%. The ex-dividend date of this dividend is Monday, March 10th. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. Elevance Health’s payout ratio is currently 26.71%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on ELV. Stephens lowered shares of Elevance Health from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $520.00 to $440.00 in a research report on Wednesday, January 22nd. Barclays increased their target price on Elevance Health from $501.00 to $512.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Wells Fargo & Company decreased their price target on Elevance Health from $483.00 to $478.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Argus reissued a “hold” rating and set a $405.40 price objective on shares of Elevance Health in a report on Wednesday, January 29th. Finally, StockNews.com raised shares of Elevance Health from a “hold” rating to a “buy” rating in a report on Saturday. Three analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $517.03.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.